New National White Paper Urges Structural Reforms to Expand Fertility Care Access in India

By BioSpectrum India's account, the Integrated Health & Wellbeing Council used World IVF Day at the 7th India IVF Summit & Awards 2026 to publish a national white paper that names the real bottleneck in Indian fertility care: money. Titled "Beyond the Burden of Infertility in India: Towards Reproductive Equity through Mission Fertility 2.1," the document calls for insurance reform and public financing as the structural fix for a system where treatment costs routinely push couples out of the clinic before the first cycle ends.

Where the fertility pipeline is failing

The paper, developed with IIHMR Delhi and authored by IHW Council Public Health Policy Lead Ritika Kumari, lays out the diagnosis plainly. India's total fertility rate has dropped below the 2.1 replacement threshold, yet fertility care still sits outside the core reproductive health framework. That gap shows up in three places: insurance products with waiting periods longer than most patients can wait, CGHS/ESIC/PSU reimbursement schedules stuck in last decade's pricing, and a private paywall that decides outcomes before diagnosis is complete.

The proposed fixes

The white paper's roadmap reads like a triage protocol:

• Recognize infertility as a core reproductive health condition, not an elective add-on.
• Run awareness through ASHAs, schools and workplaces, with dedicated male-fertility modules.
• Push employer-sponsored fertility benefits into standard workplace wellness packages.
• Strip waiting periods and tighten coverage in private insurance products.
• Modernize CGHS, ESIC and PSU reimbursement ceilings.
• Build a Fertility Benefit Package under PM-JAY for economically vulnerable families, channeled through public-private partnerships.
• Scale the state-level financing models already working in Goa, Sikkim and West Bengal.

Kamal Narayan Omer, CEO of the IHW Council, framed it bluntly: "This white paper is more than a policy document. It is a roadmap to ensure that fertility care is recognised as an essential part of reproductive healthcare rather than a privilege."

What to verify before your next cycle

Until the policy machinery catches up, the burden still lands on the patient. Before signing up for treatment, pressure-test the financing path:

• Ask the clinic for a written cycle cost breakdown — drugs, procedures, add-ons, freezing — not a verbal estimate.
• Check your insurer's waiting-period clause in writing; fertility-specific riders often carry exclusions the marketing copy hides.
• If you're a CGHS/ESIC beneficiary, confirm the current reimbursement ceiling against the protocol your clinician is recommending, not last year's schedule.
• For couples below the PM-JAY threshold, ask whether your state runs a fertility financing scheme — Goa, Sikkim and West Bengal already do.
• Push HR for an explicit fertility-benefit line in your workplace wellness policy; the white paper is now ammunition for that ask.

Shivani Sharma, COO of Bharat Serums and Vaccines, underscored the same point from the supply side: scientific advances mean nothing if patients can't reach them in time.

This is an infrastructure problem, not a medicine problem. The white paper treats it that way.